Stocks Showing Market Leadership: ResMed Earns 92 RS Rating
IBD's RS Rating tracks a stock's price performance against the market, with top growth stocks typically having a rating above 80. If a stock falls below its entry point by 7% after breaking out, it's considered a failed base.